NLRP3 and Parkinson disease: Results showed that caspase-1 concentration was significantly increased in serum of MCI and PD patients and, although not significantly, in AD, indicating that the NLRP3 inflammasome is indeed activated in these patients affected by neurodegenerative conditions.